Share Price and Basic Stock Data
Last Updated: January 3, 2026, 11:12 am
| PEG Ratio | -2.36 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
DCM Ltd operates within the castings and foundry industry, showcasing a market capitalization of ₹173 Cr. The company reported sales of ₹17.71 Cr in September 2022, which showed a modest fluctuation over the subsequent quarters, with the most recent sales figure in September 2023 standing at ₹17.82 Cr. The company’s sales peaked at ₹18.68 Cr in December 2023, indicating a slight upward trend in revenue generation. However, the trailing twelve months (TTM) revenue has remained stagnant at ₹69 Cr, reflecting a lack of significant growth compared to previous years. In the fiscal year ending March 2023, DCM Ltd recorded a total revenue of ₹69 Cr, slightly above the ₹70 Cr reported in March 2022, highlighting a challenging operating environment. The company’s operational performance is further characterized by an operating profit margin (OPM) of -1.14%, suggesting that operational costs are closely aligned with revenues, thereby limiting profitability.
Profitability and Efficiency Metrics
DCM Ltd’s profitability metrics exhibit a mixed performance. The net profit for the quarter ending September 2023 was reported at ₹-0.69 Cr, which followed a series of losses throughout the preceding quarters, including a notable loss of ₹2.22 Cr in March 2023. The company has, however, shown resilience with a net profit of ₹6.55 Cr in March 2024, indicating potential recovery. The return on equity (ROE) stood at a remarkable 68.2%, which is significantly higher than many peers in the industry, showcasing efficient use of equity capital. Meanwhile, the return on capital employed (ROCE) was recorded at 78.6%, reflecting strong operational efficiency relative to capital invested. The interest coverage ratio (ICR) of 5.78x indicates that DCM Ltd can comfortably meet its interest obligations, although the negative operating profit margins raise concerns about its overall profitability and operational efficiency.
Balance Sheet Strength and Financial Ratios
DCM Ltd’s balance sheet reveals a conservative capital structure with total borrowings of only ₹1 Cr, which is minimal in comparison to its reserves of ₹29 Cr. This low debt level contributes to a debt-to-equity ratio of 0.00, indicating a lack of financial leverage. The company’s current ratio stood at 0.91, slightly below the ideal threshold of 1, suggesting potential liquidity concerns. Additionally, the book value per share increased to ₹22.98 in March 2025, up from ₹11.12 in March 2024, reflecting an improvement in net worth despite the operational challenges faced. The price-to-book value ratio of 4.22x suggests that the stock is trading at a premium compared to its book value, which may indicate investor confidence despite the operational hurdles. The enterprise value (EV) of ₹152.22 Cr, in conjunction with the market capitalization, reflects the market’s perception of the company’s value in relation to its operational performance.
Shareholding Pattern and Investor Confidence
The shareholding structure of DCM Ltd reveals a strong promoter holding of 49.76% as of September 2025, which is indicative of significant insider confidence in the company. Foreign institutional investors (FIIs) hold a mere 0.18%, while domestic institutional investors (DIIs) account for 3.36%, suggesting limited institutional interest in the stock. The public shareholding stood at 46.69%, reflecting a broad base of retail investors. Notably, the number of shareholders has declined from 26,389 in December 2022 to 24,505 in September 2025, indicating a potential loss of investor interest or confidence. The consistency in promoter holding over the past few quarters suggests stability, yet the low institutional participation may limit liquidity and broader investor appeal. These factors combined indicate a cautious outlook among investors, which could affect the stock’s performance in the future.
Outlook, Risks, and Final Insight
DCM Ltd faces both opportunities and challenges in the current market landscape. The company’s high ROE and ROCE are significant strengths, suggesting effective management and potential for shareholder returns. However, the negative operating profit margin and fluctuating net profits pose risks that could hinder sustainable growth. The reliance on low debt levels provides financial stability, but the liquidity concerns highlighted by the current ratio below 1 warrant attention. Moving forward, DCM Ltd may benefit from operational improvements and cost management strategies to enhance profitability. On the other hand, external factors such as market demand fluctuations and industry competition could impact performance. In a favorable scenario, improved operational efficiencies could lead to a recovery in profitability, while adverse market conditions may necessitate strategic pivots to safeguard financial health. Overall, the company’s ability to navigate these challenges will be crucial for its long-term success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Intrux Ltd | 148 Cr. | 431 | 535/375 | 15.0 | 198 | 5.81 % | 22.0 % | 16.6 % | 10.0 |
| Carnation Industries Ltd | 21.2 Cr. | 61.4 | 61.4/21.1 | 3.70 | 0.00 % | 392 % | % | 10.0 | |
| Captain Technocast Ltd | 394 Cr. | 170 | 322/140 | 37.6 | 19.6 | 0.00 % | 29.4 % | 24.1 % | 10.0 |
| Nelcast Ltd | 919 Cr. | 106 | 181/78.0 | 25.0 | 65.0 | 0.47 % | 9.55 % | 6.48 % | 2.00 |
| Kirloskar Industries Ltd | 3,408 Cr. | 3,243 | 4,726/2,692 | 21.3 | 6,551 | 0.40 % | 6.72 % | 2.60 % | 10.0 |
| Industry Average | 6,469.56 Cr | 920.93 | 23.56 | 815.06 | 0.95% | 59.48% | 17.72% | 7.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.71 | 16.79 | 17.07 | 17.87 | 17.82 | 18.68 | 16.47 | 18.44 | 16.63 | 17.34 | 16.63 | 17.61 | 17.62 |
| Expenses | 17.23 | 16.43 | 17.49 | 16.61 | 17.05 | 16.96 | 17.00 | 17.40 | 16.07 | 15.68 | 16.93 | 16.34 | 17.82 |
| Operating Profit | 0.48 | 0.36 | -0.42 | 1.26 | 0.77 | 1.72 | -0.53 | 1.04 | 0.56 | 1.66 | -0.30 | 1.27 | -0.20 |
| OPM % | 2.71% | 2.14% | -2.46% | 7.05% | 4.32% | 9.21% | -3.22% | 5.64% | 3.37% | 9.57% | -1.80% | 7.21% | -1.14% |
| Other Income | 8.24 | 1.01 | 1.09 | 0.50 | 0.81 | 0.44 | 9.35 | 1.03 | 2.41 | 20.93 | 3.22 | 3.86 | 3.44 |
| Interest | -0.40 | 0.44 | 0.55 | 0.49 | 0.51 | 0.51 | 0.54 | 0.54 | 0.55 | 0.44 | 0.31 | 0.28 | 0.60 |
| Depreciation | 1.75 | 1.67 | 1.71 | 1.29 | 1.13 | 1.12 | 1.12 | 1.15 | 1.12 | 0.93 | 0.91 | 0.97 | 0.94 |
| Profit before tax | 7.37 | -0.74 | -1.59 | -0.02 | -0.06 | 0.53 | 7.16 | 0.38 | 1.30 | 21.22 | 1.70 | 3.88 | 1.70 |
| Tax % | 8.96% | 94.59% | 39.62% | 2,950.00% | 1,050.00% | 111.32% | 8.52% | 176.32% | 45.38% | 3.11% | 44.71% | 16.49% | 14.71% |
| Net Profit | 6.71 | -1.44 | -2.22 | -0.61 | -0.69 | -0.06 | 6.55 | -0.29 | 0.71 | 20.56 | 0.94 | 3.24 | 1.45 |
| EPS in Rs | 3.59 | -0.77 | -1.19 | -0.33 | -0.37 | -0.03 | 3.50 | -0.16 | 0.38 | 10.99 | 0.50 | 1.73 | 0.78 |
Last Updated: January 2, 2026, 12:03 am
Below is a detailed analysis of the quarterly data for DCM Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 17.62 Cr.. The value appears strong and on an upward trend. It has increased from 17.61 Cr. (Jun 2025) to 17.62 Cr., marking an increase of 0.01 Cr..
- For Expenses, as of Sep 2025, the value is 17.82 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.34 Cr. (Jun 2025) to 17.82 Cr., marking an increase of 1.48 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.20 Cr.. The value appears to be declining and may need further review. It has decreased from 1.27 Cr. (Jun 2025) to -0.20 Cr., marking a decrease of 1.47 Cr..
- For OPM %, as of Sep 2025, the value is -1.14%. The value appears to be declining and may need further review. It has decreased from 7.21% (Jun 2025) to -1.14%, marking a decrease of 8.35%.
- For Other Income, as of Sep 2025, the value is 3.44 Cr.. The value appears to be declining and may need further review. It has decreased from 3.86 Cr. (Jun 2025) to 3.44 Cr., marking a decrease of 0.42 Cr..
- For Interest, as of Sep 2025, the value is 0.60 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.28 Cr. (Jun 2025) to 0.60 Cr., marking an increase of 0.32 Cr..
- For Depreciation, as of Sep 2025, the value is 0.94 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.97 Cr. (Jun 2025) to 0.94 Cr., marking a decrease of 0.03 Cr..
- For Profit before tax, as of Sep 2025, the value is 1.70 Cr.. The value appears to be declining and may need further review. It has decreased from 3.88 Cr. (Jun 2025) to 1.70 Cr., marking a decrease of 2.18 Cr..
- For Tax %, as of Sep 2025, the value is 14.71%. The value appears to be improving (decreasing) as expected. It has decreased from 16.49% (Jun 2025) to 14.71%, marking a decrease of 1.78%.
- For Net Profit, as of Sep 2025, the value is 1.45 Cr.. The value appears to be declining and may need further review. It has decreased from 3.24 Cr. (Jun 2025) to 1.45 Cr., marking a decrease of 1.79 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.78. The value appears to be declining and may need further review. It has decreased from 1.73 (Jun 2025) to 0.78, marking a decrease of 0.95.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 897 | 962 | 907 | 951 | 959 | 433 | 186 | 47 | 70 | 69 | 71 | 69 | 69 |
| Expenses | 816 | 906 | 842 | 907 | 946 | 451 | 216 | 51 | 66 | 68 | 68 | 66 | 67 |
| Operating Profit | 81 | 55 | 65 | 44 | 13 | -19 | -30 | -4 | 4 | 1 | 3 | 3 | 2 |
| OPM % | 9% | 6% | 7% | 5% | 1% | -4% | -16% | -8% | 5% | 2% | 5% | 4% | 4% |
| Other Income | 21 | 9 | 8 | 16 | 9 | 49 | 27 | 4 | 42 | 13 | 11 | 28 | 31 |
| Interest | 24 | 33 | 34 | 30 | 26 | 13 | 11 | 9 | 6 | 2 | 2 | 2 | 2 |
| Depreciation | 23 | 41 | 36 | 36 | 36 | 17 | 13 | 9 | 8 | 7 | 5 | 4 | 4 |
| Profit before tax | 56 | -10 | 2 | -7 | -40 | -0 | -27 | -17 | 32 | 5 | 8 | 25 | 28 |
| Tax % | 35% | -7% | -69% | 2% | 0% | 0% | 7% | 2% | 6% | 52% | 32% | 11% | |
| Net Profit | 36 | -9 | 3 | -7 | -40 | -0 | -29 | -18 | 30 | 2 | 5 | 22 | 26 |
| EPS in Rs | 21.67 | -2.49 | 1.78 | -3.81 | -21.52 | -0.14 | -15.67 | -9.54 | 16.13 | 1.25 | 2.79 | 11.72 | 14.00 |
| Dividend Payout % | 7% | -120% | 84% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -125.00% | 133.33% | -333.33% | -471.43% | 100.00% | 37.93% | 266.67% | -93.33% | 150.00% | 340.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 258.33% | -466.67% | -138.10% | 571.43% | -62.07% | 228.74% | -360.00% | 243.33% | 190.00% |
DCM Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -23% |
| 5 Years: | -18% |
| 3 Years: | 0% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 19% |
| 3 Years: | 11% |
| TTM: | 362% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 35% |
| 3 Years: | 13% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 46% |
| Last Year: | 69% |
Last Updated: September 5, 2025, 2:40 am
Balance Sheet
Last Updated: December 10, 2025, 2:34 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 17 | 17 | 17 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 |
| Reserves | 205 | 192 | 211 | 198 | 158 | 158 | -21 | -38 | -7 | -4 | 2 | 24 | 29 |
| Borrowings | 320 | 353 | 321 | 361 | 289 | 249 | 29 | 32 | 24 | 1 | 2 | 1 | 1 |
| Other Liabilities | 174 | 153 | 112 | 94 | 162 | 145 | 95 | 113 | 81 | 99 | 91 | 81 | 82 |
| Total Liabilities | 717 | 715 | 661 | 671 | 627 | 571 | 122 | 126 | 117 | 115 | 113 | 125 | 131 |
| Fixed Assets | 184 | 269 | 273 | 232 | 197 | 173 | 62 | 52 | 43 | 35 | 34 | 31 | 30 |
| CWIP | 74 | 16 | 0 | 1 | 2 | 1 | 0 | 0 | -0 | -0 | -0 | -0 | -0 |
| Investments | 2 | 1 | 1 | 19 | 14 | 12 | 7 | 6 | 11 | 12 | 11 | 24 | 27 |
| Other Assets | 457 | 429 | 387 | 420 | 414 | 386 | 53 | 68 | 63 | 68 | 68 | 70 | 74 |
| Total Assets | 717 | 715 | 661 | 671 | 627 | 571 | 122 | 126 | 117 | 115 | 113 | 125 | 131 |
Below is a detailed analysis of the balance sheet data for DCM Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00 Cr..
- For Reserves, as of Sep 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 5.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 82.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 81.00 Cr. (Mar 2025) to 82.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 131.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 125.00 Cr. (Mar 2025) to 131.00 Cr., marking an increase of 6.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 30.00 Cr.. The value appears to be declining and may need further review. It has decreased from 31.00 Cr. (Mar 2025) to 30.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Mar 2025) to 27.00 Cr., marking an increase of 3.00 Cr..
- For Other Assets, as of Sep 2025, the value is 74.00 Cr.. The value appears strong and on an upward trend. It has increased from 70.00 Cr. (Mar 2025) to 74.00 Cr., marking an increase of 4.00 Cr..
- For Total Assets, as of Sep 2025, the value is 131.00 Cr.. The value appears strong and on an upward trend. It has increased from 125.00 Cr. (Mar 2025) to 131.00 Cr., marking an increase of 6.00 Cr..
Notably, the Reserves (29.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -239.00 | -298.00 | -256.00 | -317.00 | -276.00 | -268.00 | -59.00 | -36.00 | -20.00 | 0.00 | 1.00 | 2.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 57 | 61 | 52 | 41 | 45 | 83 | 20 | 79 | 80 | 78 | 82 | 75 |
| Inventory Days | 159 | 116 | 154 | 147 | 141 | 516 | 72 | |||||
| Days Payable | 56 | 41 | 41 | 29 | 70 | 195 | 304 | |||||
| Cash Conversion Cycle | 160 | 136 | 165 | 159 | 116 | 403 | -211 | 79 | 80 | 78 | 82 | 75 |
| Working Capital Days | 28 | 19 | 10 | 13 | 11 | 19 | -149 | -540 | -193 | -158 | -172 | -179 |
| ROCE % | 13% | 4% | 7% | 4% | -3% | 3% | -18% | -44% | 92% | 26% | 50% | 79% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 11.73 | 2.79 | 1.25 | 16.15 | -9.55 |
| Diluted EPS (Rs.) | 11.73 | 2.79 | 1.25 | 16.15 | -9.55 |
| Cash EPS (Rs.) | 3.24 | 5.54 | 4.36 | 17.74 | -4.12 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 22.98 | 11.12 | 8.01 | 6.39 | -10.21 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 22.98 | 11.12 | 8.01 | 6.39 | -10.21 |
| Revenue From Operations / Share (Rs.) | 36.97 | 37.93 | 37.18 | 37.36 | 25.38 |
| PBDIT / Share (Rs.) | 5.65 | 7.92 | 6.91 | 21.96 | 0.78 |
| PBIT / Share (Rs.) | 3.45 | 5.43 | 3.16 | 17.60 | -4.16 |
| PBT / Share (Rs.) | 2.47 | 4.34 | 1.99 | 14.44 | -8.83 |
| Net Profit / Share (Rs.) | 1.04 | 3.05 | 0.62 | 13.38 | -9.06 |
| NP After MI And SOA / Share (Rs.) | 11.73 | 2.79 | 1.25 | 16.15 | -9.55 |
| PBDIT Margin (%) | 15.29 | 20.88 | 18.57 | 58.78 | 3.10 |
| PBIT Margin (%) | 9.33 | 14.33 | 8.50 | 47.12 | -16.39 |
| PBT Margin (%) | 6.69 | 11.43 | 5.35 | 38.66 | -34.81 |
| Net Profit Margin (%) | 2.81 | 8.05 | 1.66 | 35.82 | -35.72 |
| NP After MI And SOA Margin (%) | 31.74 | 7.34 | 3.35 | 43.23 | -37.63 |
| Return on Networth / Equity (%) | 51.06 | 25.06 | 15.59 | 252.68 | 0.00 |
| Return on Capital Employeed (%) | 9.78 | 19.78 | 11.83 | 73.15 | -68.89 |
| Return On Assets (%) | 17.51 | 4.59 | 2.04 | 25.80 | -14.19 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 1.95 | -1.32 |
| Asset Turnover Ratio (%) | 0.57 | 0.62 | 0.60 | 0.01 | 0.00 |
| Current Ratio (X) | 0.91 | 0.81 | 0.71 | 0.67 | 0.47 |
| Quick Ratio (X) | 0.78 | 0.67 | 0.52 | 0.52 | 0.35 |
| Inventory Turnover Ratio (X) | 8.09 | 0.13 | 0.00 | 0.00 | -0.02 |
| Interest Coverage Ratio (X) | 5.78 | 7.22 | 5.89 | 6.95 | 0.16 |
| Interest Coverage Ratio (Post Tax) (X) | 2.06 | 3.78 | 1.53 | 5.23 | -0.94 |
| Enterprise Value (Cr.) | 152.22 | 111.71 | 119.03 | 164.71 | 61.25 |
| EV / Net Operating Revenue (X) | 2.20 | 1.58 | 1.71 | 2.36 | 1.29 |
| EV / EBITDA (X) | 14.41 | 7.55 | 9.23 | 4.02 | 41.65 |
| MarketCap / Net Operating Revenue (X) | 2.62 | 1.89 | 1.89 | 2.22 | 0.96 |
| Price / BV (X) | 4.22 | 6.45 | 8.77 | 12.98 | -2.39 |
| Price / Net Operating Revenue (X) | 2.62 | 1.89 | 1.89 | 2.22 | 0.96 |
| EarningsYield | 0.12 | 0.03 | 0.01 | 0.19 | -0.39 |
After reviewing the key financial ratios for DCM Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 11.73. This value is within the healthy range. It has increased from 2.79 (Mar 24) to 11.73, marking an increase of 8.94.
- For Diluted EPS (Rs.), as of Mar 25, the value is 11.73. This value is within the healthy range. It has increased from 2.79 (Mar 24) to 11.73, marking an increase of 8.94.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.24. This value is within the healthy range. It has decreased from 5.54 (Mar 24) to 3.24, marking a decrease of 2.30.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.98. It has increased from 11.12 (Mar 24) to 22.98, marking an increase of 11.86.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.98. It has increased from 11.12 (Mar 24) to 22.98, marking an increase of 11.86.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 36.97. It has decreased from 37.93 (Mar 24) to 36.97, marking a decrease of 0.96.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.65. This value is within the healthy range. It has decreased from 7.92 (Mar 24) to 5.65, marking a decrease of 2.27.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.45. This value is within the healthy range. It has decreased from 5.43 (Mar 24) to 3.45, marking a decrease of 1.98.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.47. This value is within the healthy range. It has decreased from 4.34 (Mar 24) to 2.47, marking a decrease of 1.87.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 2. It has decreased from 3.05 (Mar 24) to 1.04, marking a decrease of 2.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.73. This value is within the healthy range. It has increased from 2.79 (Mar 24) to 11.73, marking an increase of 8.94.
- For PBDIT Margin (%), as of Mar 25, the value is 15.29. This value is within the healthy range. It has decreased from 20.88 (Mar 24) to 15.29, marking a decrease of 5.59.
- For PBIT Margin (%), as of Mar 25, the value is 9.33. This value is below the healthy minimum of 10. It has decreased from 14.33 (Mar 24) to 9.33, marking a decrease of 5.00.
- For PBT Margin (%), as of Mar 25, the value is 6.69. This value is below the healthy minimum of 10. It has decreased from 11.43 (Mar 24) to 6.69, marking a decrease of 4.74.
- For Net Profit Margin (%), as of Mar 25, the value is 2.81. This value is below the healthy minimum of 5. It has decreased from 8.05 (Mar 24) to 2.81, marking a decrease of 5.24.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 31.74. This value exceeds the healthy maximum of 20. It has increased from 7.34 (Mar 24) to 31.74, marking an increase of 24.40.
- For Return on Networth / Equity (%), as of Mar 25, the value is 51.06. This value is within the healthy range. It has increased from 25.06 (Mar 24) to 51.06, marking an increase of 26.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.78. This value is below the healthy minimum of 10. It has decreased from 19.78 (Mar 24) to 9.78, marking a decrease of 10.00.
- For Return On Assets (%), as of Mar 25, the value is 17.51. This value is within the healthy range. It has increased from 4.59 (Mar 24) to 17.51, marking an increase of 12.92.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.57. It has decreased from 0.62 (Mar 24) to 0.57, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1.5. It has increased from 0.81 (Mar 24) to 0.91, marking an increase of 0.10.
- For Quick Ratio (X), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 1. It has increased from 0.67 (Mar 24) to 0.78, marking an increase of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.09. This value exceeds the healthy maximum of 8. It has increased from 0.13 (Mar 24) to 8.09, marking an increase of 7.96.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.78. This value is within the healthy range. It has decreased from 7.22 (Mar 24) to 5.78, marking a decrease of 1.44.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.06. This value is below the healthy minimum of 3. It has decreased from 3.78 (Mar 24) to 2.06, marking a decrease of 1.72.
- For Enterprise Value (Cr.), as of Mar 25, the value is 152.22. It has increased from 111.71 (Mar 24) to 152.22, marking an increase of 40.51.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.20. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 2.20, marking an increase of 0.62.
- For EV / EBITDA (X), as of Mar 25, the value is 14.41. This value is within the healthy range. It has increased from 7.55 (Mar 24) to 14.41, marking an increase of 6.86.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.62. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 2.62, marking an increase of 0.73.
- For Price / BV (X), as of Mar 25, the value is 4.22. This value exceeds the healthy maximum of 3. It has decreased from 6.45 (Mar 24) to 4.22, marking a decrease of 2.23.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.62. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 2.62, marking an increase of 0.73.
- For EarningsYield, as of Mar 25, the value is 0.12. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.12, marking an increase of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DCM Ltd:
- Net Profit Margin: 2.81%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.78% (Industry Average ROCE: 59.48%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 51.06% (Industry Average ROE: 17.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.06
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.78
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 6.6 (Industry average Stock P/E: 23.56)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.81%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Castings/Foundry | Unit Nos. 2050 to 2052, 2nd Floor, Plaza - II, Central Square, New Delhi Delhi 110006 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Jitendra Tuli | Chairman |
| Mr. Vinay Sharma | Managing Director |
| Mr. Ajay Vir Jakhar | Director |
| Dr. Kavita A Sharma | Director |
| Mr. Aditya Katoch | Director |
| Mr. Shayam Sunder Sharma | Director |
| Mr. Sumant Bharat Ram | Director |
| Mr. Yuv Bharat Ram | Director |
| Mr. Rahil Bharat Ram | Director |
FAQ
What is the intrinsic value of DCM Ltd?
DCM Ltd's intrinsic value (as of 03 January 2026) is ₹93.66 which is 1.25% higher the current market price of ₹92.50, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹173 Cr. market cap, FY2025-2026 high/low of ₹136/89.0, reserves of ₹29 Cr, and liabilities of ₹131 Cr.
What is the Market Cap of DCM Ltd?
The Market Cap of DCM Ltd is 173 Cr..
What is the current Stock Price of DCM Ltd as on 03 January 2026?
The current stock price of DCM Ltd as on 03 January 2026 is ₹92.5.
What is the High / Low of DCM Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of DCM Ltd stocks is ₹136/89.0.
What is the Stock P/E of DCM Ltd?
The Stock P/E of DCM Ltd is 6.60.
What is the Book Value of DCM Ltd?
The Book Value of DCM Ltd is 25.5.
What is the Dividend Yield of DCM Ltd?
The Dividend Yield of DCM Ltd is 0.00 %.
What is the ROCE of DCM Ltd?
The ROCE of DCM Ltd is 78.6 %.
What is the ROE of DCM Ltd?
The ROE of DCM Ltd is 68.2 %.
What is the Face Value of DCM Ltd?
The Face Value of DCM Ltd is 10.0.